Martin Ostrowski

Martin Ostrowski, MS, JD, is Chief Technology Officer at Ryne Bio. Recently as co-Founder of two biotech spin-outs in the advanced medicine sector, he raised over $15MM while leading IP licensing & portfolio development and operations. Martin previously served as Director of Intellectual Property and Business Development at Cellscript, practiced law at Sughrue Mion, PLLC, and led the business development operations at Arteriocyte and Arteriocyte Medical Systems. His professional career has spanned academic research, to business development and commercialization activities, to prosecuting and litigating domestic and international intellectual property, to leadership roles in different biotechnology and pharma-based commercial entities.